B. Riley Wealth Advisors, Inc. - FORTRESS BIOTECH INC ownership

FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 85 filers reported holding FORTRESS BIOTECH INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
B. Riley Wealth Advisors, Inc. ownership history of FORTRESS BIOTECH INC
ValueSharesWeighting
Q3 2023$42,006
-56.3%
144,700
-17.2%
0.00%
-50.0%
Q2 2023$96,140
-35.4%
174,800
-3.7%
0.00%
-50.0%
Q1 2023$148,912
+38.0%
181,600
+10.2%
0.00%
+33.3%
Q4 2022$107,945
-24.0%
164,8000.0%0.00%
-25.0%
Q3 2022$142,000
+6.0%
164,800
+3.8%
0.00%
-33.3%
Q2 2022$134,000
-32.3%
158,800
+9.1%
0.01%0.0%
Q1 2022$198,000
-29.0%
145,550
+30.5%
0.01%
-25.0%
Q4 2021$279,000
+62.2%
111,550
+109.1%
0.01%
+60.0%
Q3 2021$172,000
+9.6%
53,350
+21.2%
0.01%0.0%
Q2 2021$157,000
-26.6%
44,010
-27.3%
0.01%
-37.5%
Q1 2021$214,000
+21.6%
60,510
+9.0%
0.01%
-11.1%
Q4 2020$176,000
-38.2%
55,510
-22.7%
0.01%
-40.0%
Q3 2020$285,000
+85.1%
71,796
+24.9%
0.02%
+50.0%
Q2 2020$154,000
-1.9%
57,491
-30.7%
0.01%
-23.1%
Q1 2020$157,000
-6.0%
82,991
+22.5%
0.01%
-7.1%
Q4 2019$167,000
+101.2%
67,759
+15.7%
0.01%
+75.0%
Q3 2019$83,000
-2.4%
58,551
+5.9%
0.01%
-11.1%
Q2 2019$85,000
-3.4%
55,309
-2.0%
0.01%
-18.2%
Q1 2019$88,000
+114.6%
56,417
+18.4%
0.01%
+83.3%
Q4 2018$41,000
-40.6%
47,667
+10.6%
0.01%
-25.0%
Q3 2018$69,000
-38.4%
43,102
+15.0%
0.01%
-46.7%
Q2 2018$112,000
-34.5%
37,491
-0.3%
0.02%
-37.5%
Q1 2018$171,000
+37.9%
37,621
+21.1%
0.02%
+41.2%
Q4 2017$124,000
-0.8%
31,064
+10.4%
0.02%
-19.0%
Q3 2017$125,000
-9.4%
28,133
-2.5%
0.02%
-16.0%
Q2 2017$138,000
+76.9%
28,850
+38.4%
0.02%
+56.2%
Q1 2017$78,000
+36.8%
20,8500.0%0.02%
+33.3%
Q4 2016$57,000
-20.8%
20,850
-13.5%
0.01%
-14.3%
Q3 2016$72,000
+10.8%
24,1000.0%0.01%
+7.7%
Q2 2016$65,000
-13.3%
24,1000.0%0.01%
-23.5%
Q1 2016$75,000
+10.3%
24,1000.0%0.02%
+21.4%
Q4 2015$68,000
+41.7%
24,100
+33.1%
0.01%
+16.7%
Q3 2015$48,00018,1000.01%
Other shareholders
FORTRESS BIOTECH INC shareholders Q1 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 3,887,500$12,323,0001.61%
Nantahala Capital Management 8,680,909$27,518,0000.85%
SHIKIAR ASSET MANAGEMENT INC 558,500$1,770,0000.64%
CPWM, LLC 506,267$1,605,0000.15%
Sandbox Financial Partners, LLC 14,650$46,0000.04%
Sepio Capital, LP 134,748$427,0000.04%
683 Capital Management, LLC 200,000$635,0000.03%
GSA CAPITAL PARTNERS LLP 22,928$73,0000.01%
Virtu Financial LLC 33,333$106,0000.01%
B. Riley Wealth Advisors, Inc. 55,510$176,0000.01%
View complete list of FORTRESS BIOTECH INC shareholders